Skip to main content
Clinical Trials/DRKS00023831
DRKS00023831
Completed
N/A

Cardiac Injury after survived SARS-CoV2-infection (COVID19)

Franzen Institut0 sites92 target enrollmentApril 6, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
U07.1
Sponsor
Franzen Institut
Enrollment
92
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 6, 2021
End Date
December 31, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Franzen Institut

Eligibility Criteria

Inclusion Criteria

  • Age 18\-80 years, signed informed consent, 1st SARS\-CoV2\-Infection (COVID19\) confirmed with PCR from nasal and throat swab

Exclusion Criteria

  • Age \< 18 years or \> 80 years, no informed consent, ESKD, dementia, patient with myocarditis/brain infarction/myocardial infarction/cardiac surgery/pacemaker\-implantation in the medical history, Patients after heart transplant, congenital heart diseases, re\-infection with SARS\-CoV2

Outcomes

Primary Outcomes

Not specified

Similar Trials